UNIVERSITY OF MIAMI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
Oxygenation Instability and Maturation of Control of Breathing in Premature Infants
Completed
- Conditions
- Infant,Premature
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 70
- Registration Number
- NCT03445689
- Locations
- 🇺🇸
NICU at Holtz Children's Hospital, Miami, Florida, United States
Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer
Not Applicable
Completed
- Conditions
- Head and Neck CancerOropharynx Cancer
- Interventions
- Other: Prophylactic Swallowing Home Exercise ProgramOther: Clinician-Directed Prophylactic Swallowing Exercises
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 30
- Registration Number
- NCT03435471
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
Phase 1
Withdrawn
- Conditions
- Leiomyosarcoma
- Interventions
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- University of Miami
- Registration Number
- NCT03437070
Training and Parkinson's
Not Applicable
Completed
- Conditions
- Parkinson DiseaseWeight-Lifting Exercise Program
- Interventions
- Other: Power TrainingOther: Strength Training
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 35
- Registration Number
- NCT03434327
- Locations
- 🇺🇸
Max Orovitz Laboratories, Coral Gables, Florida, United States
Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
Completed
- Conditions
- Oxygen Therapy
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 35
- Registration Number
- NCT03431818
- Locations
- 🇺🇸
NICU at Holtz Children's Hospital, Miami, Florida, United States
Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration
Not Applicable
Completed
- Conditions
- Mucositis OralHead and Neck CancerDehydrationLung Cancer
- Interventions
- Behavioral: Symptom Management Education and Nurse CoachingBehavioral: Drinks Diary
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2019-09-13
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 11
- Registration Number
- NCT03416582
- Locations
- 🇺🇸
University of Miami Sylvester Cancer Center, Miami, Florida, United States
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
Phase 1
Completed
- Conditions
- Hypoplastic Left Heart Syndrome
- Interventions
- Biological: c-kit+ cells
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Joshua M Hare
- Target Recruit Count
- 25
- Registration Number
- NCT03406884
- Locations
- 🇺🇸
Emory University Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States
🇺🇸University of Maryland - Division of Cardiac Surgery, Baltimore, Maryland, United States
🇺🇸Michigan Medicine Congenital Heart Center/C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
Heart Failure Medication Adherence
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Behavioral: Meds to BedsBehavioral: Electronic Prescription
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2019-11-07
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 40
- Registration Number
- NCT03402750
- Locations
- 🇺🇸
Jackson Memorial Hospital, Miami, Florida, United States
Compuflo Instrument for Thoracic ES Identification
Not Applicable
Terminated
- Conditions
- ThoracicAnesthesia
- Interventions
- Device: Compuflo Epidural Instrument
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 2
- Registration Number
- NCT03376256
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Phase 2
Terminated
- Conditions
- Cervical Cancer
- Interventions
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 17
- Registration Number
- NCT03367871
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath